BioNTech SE

Industry

  • Biotechnology
    • Large Molecule
    • Antisense, Oligonucleotides
  • Pharmaceuticals

Other Names/Subsidiaries

  • 4SC Discovery
  • Aexerna Therapeutics
  • BioNTech
  • BioNTech Diagnostics
  • BioNTech Protein Therapeutics
  • BioNTech RNA Pharmaceuticals
  • BioNTech Small Molecules
  • BioNTech US
  • Biopharmaceutical New Technologies
  • Biotheus
  • Cell & Gene Therapies
  • EUFETS & JPT Peptide Technologies
  • InstaDeep
  • Neon Therapeutics
  • PhagoMed
  • Ribological.
See more in Biomedtracker

Latest on BioNTech SE

Scrip

BioNTech Seeks New Partners To Boost PD-L1xVEGF Competitor

 
• By Andrew McConaghie

BioNTech made its name and fortune with its Pfizer-partnered COVID-19 vaccine, Comirnaty, but this year could be a turning point in its bid to diversify and become a major oncology company as well. Th

Scrip

Genmab Relies On Pipeline As J&J Opts Out Of Next-Gen Darzalex

 
• By Mandy Jackson

The pressure on Genmab to deliver positive results from its late-stage development programs has intensified now that the most closely watched event on the company’s 2025 calendar has arrived and the r

Scrip

BioNTech Can Rival Summit In VEGF x PD-(L)1 Bispecifics

 
• By Andrew McConaghie

Summit Therapeutics and its partner Akeso have a commanding lead in the VEGF x PD-(L)1 bispecific cancer immunotherapy field, but BioNTech is also focused on being a major contender. Several key clini

Scrip

Novavax Looks To Right Its Ship Amid Revenue Slump

 
• By Alaric DeArment

A partnership with French drug maker Sanofi, leveraging its platform and pipeline to find new partnerships, and advancing the pipeline form the three main strategic priorities for Novavax as it works